Bengaluru: AI Healthcare Specialist raised $7.2 million in the Series A round led by Leo Capital, with participation from Sanos Capital. Existing supporters W Health Venture and 2070 Health, which incubated the company in 2023, continued to support it.Co-founder and CEO Sanchit Mullick told TOI that the funds will be used to expand the teams that have come into the market and commercialize pre-built AI solutions such as BioCanvas and Prism AI. “So far, we have actually been founder-led sales. Now we want to invest in creating commercial grades of solutions while expanding our market education efforts,” he said.Mullick, a former Infosys executive who incubated AI services at IT Major, teamed up with co-founder Dr. Salim, formerly a pediatric vascular surgeon at Boston Children's Hospital. “We arrived at this paper based on 20 years of digital plumbing in US healthcare through EHR and RCMS. There was a gold mine for data, but it was hardly clear which business problems to solve,” Mullick said.Clearly it started with combining clinical insights and deep technical capabilities to address the issue definition of US healthcare and life sciences companies. “We wanted to take a service-first approach rather than building our products and pushing them into the market,” Malick added.The company says solutions such as Biocanvas will integrate structured EHR data with CTS and MRI imaging data to help in areas such as oncology, clinical trial recruitment and patient cohort creation. It also pilots AI workflow automation tools such as PRISM AI.Mullick said the adoption barriers are not about data availability, but about regulations and culture. “One uncertainty is how regulatory landscapes are shaped for healthcare AI. The other is psychological safety. Employees often fear that AI tools will replace them,” he said. To address this, we have built a design center in Providence, Rhode Island, focusing on user experience and integration into existing workflows.The company said it works with clients, ranging from major pharmaceutical companies to healthcare delivery networks and digital health innovators. Recent developments include $40 billion in improved patient compliance for US medical device manufacturers.
